The FDA and Robert F. Kennedy Jr. are focusing on the need for expedited drug approval timelines.
2 reports, 2 independent
Updated Aug 27
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA and Robert F. Kennedy Jr. are focusing on the need for expedited drug approval timelines.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Donald Trump, Robert F. Kennedy Jr., and Katie Britt are seeking access to an experimental cancer drug.Sub-event
Advocacy for expedited drug approval timelines involving the FDA and Robert F. Kennedy Jr.1 source
Keep exploring
The entities involved
- FDA
-
Robert F. Kennedy Jr.
American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)
Related events
- AMA urges FDA to maintain standards as federal government implements marijuana rescheduling order amid GAO findings of regulatory deficiencies.
- Donald Trump instructed the FDA to accelerate the drug review process.
- FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.
- FDA placed a clinical hold on the drug application submitted by Bright Minds Biosciences Inc.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.